Early experiences with usage of long‐acting injectable cabotegravir among adults in rural Ugandan and Kenyan communities: qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

Abstract Introduction Despite oral HIV pre‐exposure prophylaxis (PrEP) effectiveness, uptake and adherence remains a challenge. Newer HIV prevention technologies, including long‐acting injectable cabotegravir (CAB‐LA), are promising for addressing known barriers to oral PrEP uptake and adherence, ye...

Descripció completa

Dades bibliogràfiques

Autors principals:	Carol S. Camlin, Anjeline Onyango, Jason Johnson‐Peretz, Cecilia Akatukwasa, Titus O. Arunga, Lawrence Owino, Frederick Atwine, Ambrose Byamukama, Andrew Mutabazi, Laura B. Balzer, Maggie Czarnogorski, Elijah Kakande, Helen Sunday, Gabriel Chamie, James Ayieko, Maya Petersen, Nicole Sutter, Moses R. Kamya, Diane V. Havlir, Jane Kabami
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-11-01
Col·lecció:	Journal of the International AIDS Society
Matèries:	HIV prevention HIV pre‐exposure prophylaxis PrEP long‐acting cabotegravir CAB‐LA Kenya
Accés en línia:	https://doi.org/10.1002/jia2.70059
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!